This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goulet, B. Articles by Nepveu, A. Search for Related Content PubMed PubMed Citation Articles by Goulet, B. Articles by Nepveu, A.

---

Cell Cycle, Cell Death, and Senescence

Increased Expression and Activity of Nuclear Cathepsin L in Cancer Cells Suggests a Novel Mechanism of Cell Transformation

¹ Molecular Oncology Group, McGill University Health Center; Departments of ² Biochemistry, ³ Medicine, and ⁴ Oncology, McGill University, Montreal, Quebec, Canada; ⁵ Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India; ⁶ Institute of Physiological Chemistry, Martin-Luther-University Halle-Wittenberg, Halle, Germany; and ⁷ Department of Pathology, Stanford Medical School, Stanford, California

Requests for reprints: Alain Nepveu, Molecular Oncology Group, McGill University Health Center, 687 Pine Avenue West, Montreal, Quebec, Canada H3A 1A1. Phone: 514-934-1934, ext. 35842; Fax: 514-843-1478. E-mail: alain.nepveu{at}mcgill.ca

It is generally accepted that the role of cathepsin L in cancer involves its activities outside the cells once it has been secreted. However, cathepsin L isoforms that are devoid of a signal peptide were recently shown to be present in the nucleus where they proteolytically process the CCAAT-displacement protein/cut homeobox (CDP/Cux) transcription factor. A role for nuclear cathepsin L in cell proliferation could be inferred from the observation that the CDP/Cux processed isoform can accelerate entry into S phase. Here, we report that in many transformed cells the proteolytic processing of CDP/Cux is augmented and correlates with increased cysteine protease expression and activity in the nucleus. Taking advantage of an antibody that recognizes the prodomain of human cathepsin L, we showed that human cells express short cathepsin L species that do not contain a signal peptide, do not transit through the endoplasmic reticulum, are not glycosylated, and localize to the nucleus. We also showed that transformation by the ras oncogene causes rapid increases both in the production of short nuclear cathepsin L isoforms and in the processing of CDP/Cux. Using a cell-based assay, we showed that a cell-permeable inhibitor of cysteine proteases is able to delay the progression into S phase and the proliferation in soft agar of ras-transformed cells, whereas the non–cell-permeable inhibitor had no effect. Taken together, these results suggest that the role of cathepsin L in cancer might not be limited to its extracellular activities but may also involve its processing function in the nucleus. (Mol Cancer Res 2007;5(9):899–907)

This article has been cited by other articles:

				C. Cadieux, R. Harada, M. Paquet, O. Cote, M. Trudel, A. Nepveu, and M. Bouchard Polycystic Kidneys Caused by Sustained Expression of Cux1 Isoform p75 J. Biol. Chem., May 16, 2008; 283(20): 13817 - 13824. [Abstract] [Full Text] [PDF]

				B. Goulet, Y. Markovic, L. Leduy, and A. Nepveu Proteolytic Processing of Cut Homeobox 1 by Neutrophil Elastase in the MV4;11 Myeloid Leukemia Cell Line Mol. Cancer Res., April 1, 2008; 6(4): 644 - 653. [Abstract] [Full Text] [PDF]

				R. Harada, C. Vadnais, L. Sansregret, L. Leduy, G. Berube, F. Robert, and A. Nepveu Genome-wide location analysis and expression studies reveal a role for p110 CUX1 in the activation of DNA replication genes Nucleic Acids Res., January 17, 2008; 36(1): 189 - 202. [Abstract] [Full Text] [PDF]